Express Scripts Wegovy prior authorization is a coverage review, not a denial. Your doctor sends proof, and Express Scripts checks it against your plan's rules. Cigna's standard adult weight-loss criteria include a pre-GLP-1 BMI of 30+ (or 27+ with a listed condition) and 3 months of diet and behavior changes. Initial approval: 8 months when the full criteria are met. Source: Cigna IP0814.
Disclosure: Some links on this page are affiliate links. We label every one. If you use them, we may earn a commission at no extra cost to you. That never changes the rules we report. How we make money
The catch: that BMI line isn't the same for everyone who carries an Express Scripts card. We found three published versions of the Wegovy rules — BMI 30, 32 and 35 — and one of them adds a weight-app rule. Below, you'll see how the versions differ and what to ask your plan to confirm yours.
Your answer changes if: your employer left weight-loss drugs out of your plan · your plan uses a stricter version (BMI 32 or 35) · you've had a heart attack, stroke or PAD · you have MASH with liver scarring · you're 12 to 17 · you have TRICARE or Medicare.
Jump to your situation: My doctor hasn't filed yet · It's pending · I got denied · My approval is ending · My plan won't cover it
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
Express Scripts Wegovy rules at a glance: Cigna’s standard adult weight-loss policy
| Rule | What it means for you |
|---|---|
| Your plan covers weight-loss drugs | Your plan must cover this use or offer an applicable exception or override. A routine PA does not add an excluded benefit. |
| BMI | 30 or higher before your first GLP-1, or 27 or higher with 1 weight-related health problem |
| Diet proof | At least 3 months of diet and behavior changes in your records |
| Who files | Your doctor's office supplies the clinical answers |
| First approval | 8 months |
| To renew | At least 5% loss from your pre-GLP-1 weight, plus the other continuation criteria, for a 1-year renewal |
Source: Cigna’s Wegovy Injection policy IP0814, effective Sept. 1, 2026. These are selected policy rules, not a coverage promise for every Express Scripts member. Your plan may use a different version — see the full chart below.
This page is for you if you have an Express Scripts card through a job, union or Cigna plan, your doctor prescribed Wegovy (the pen, Wegovy HD or the pill), and you were told it needs prior authorization — or you got a denial or a renewal notice.
Start with a different section or guide if:
- You have TRICARE → TRICARE rules below or our TRICARE Wegovy prior authorization guide
- You're on Medicare → Part D versus Medicare GLP-1 Bridge
- You were prescribed Zepbound → Express Scripts Zepbound prior authorization
- You only want to know if your plan covers Wegovy at all → Coverage requirement or plan exclusion?
What we actually verified: On Sept. 22, 2026, we read Cigna's current Wegovy policies (the standard, BMI 32 and BMI 35 versions), Express Scripts' coverage-review and pharmacy FAQs, Evernorth's prior authorization page, Novo Nordisk's savings terms and prices, Ro's pricing and insurance pages, CMS's Medicare GLP-1 Bridge rules, and the federal appeal rules. We did not see your plan's exact version, look at anyone's account, or file a prior authorization. The worksheet below helps you get those missing answers.
▶ Get my Wegovy PA checklist and call script Free to read, copy or print. No signup.
What does "prior authorization required" mean for Wegovy?
Answer: It means your plan needs more information before it pays for Wegovy — it is not a denial. Express Scripts calls this a "coverage review." Your doctor supplies the clinical details; in some cases, a pharmacist can help. Your account can show an approved, denied or withdrawn request. Source: Express Scripts.
Here's how it usually starts. You go to pick up Wegovy, and the pharmacy says it "needs a PA." That's the pharmacy getting an alert from Express Scripts. Now someone has to prove you meet your plan's rules. Express Scripts says that part comes from your doctor (in some cases, your pharmacist).
Three quick terms:
- Prior authorization (PA): your plan checks its rules before it pays for a drug.
- Express Scripts: a pharmacy benefit manager (PBM) — the company that runs the prescription side of your health plan. It's part of Evernorth, which is owned by The Cigna Group.
- Your plan: the health benefit you enrolled in. Your employer or insurer sets its benefits; Express Scripts applies the prescription benefit rules. Sources: Express Scripts and Cigna.
Start here: what's happening, and who to call first
| What you're seeing | What it could mean | Call first | What to ask |
|---|---|---|---|
| Pharmacy says "prior authorization required" | No usable approval for the claim the pharmacy submitted | Your doctor's office | "Can you file my Wegovy prior authorization electronically?" |
| The office says it was sent, but nothing shows up | It may not have arrived, or it's incomplete | Doctor's office, then Express Scripts | "What date was it sent, and how? Is there a reference number?" |
| Your status says "withdrawn" | The request closed without a decision | Doctor's office | "Why was it withdrawn? Can you refile?" |
| You got a denial letter | Rules not met, missing information, or not covered | Read the letter, then call your doctor | "What reason and policy are listed? When is the appeal deadline?" |
| Approved, but the pharmacy still won't fill it | A claim, product, pharmacy, stock or price issue — ask for the exact message | The pharmacy | "What exact message comes back when you run it?" |
| Your approval ran out | Time to renew | Doctor's office | "Can you file the renewal with my starting and current weight?" |
This is our step-by-step guide, built from Express Scripts’ own member FAQs. The labels in your account may look different. The table gives questions to ask, not a diagnosis of why your claim failed.
Prior authorization or plan exclusion? This matters most
Think of a prior authorization as a locked door. The paperwork has to show you meet the rules for that door.
A plan exclusion is a wall. Your plan left that use out of the benefit. Sending the same PA again does not add coverage — you need to check for an exception or override.
If your letter says "not a covered benefit," "excluded" or "weight-loss drugs are not covered," you're looking at a wall. Walls are common. In KFF’s 2025 survey, 19% of firms with at least 200 workers that offered health benefits covered GLP-1s primarily for weight loss in their largest plan. That is a measure of those employers, not all health plans or Express Scripts members. Source: KFF.
A wall with a side gate: weight-loss "overrides"
Here's the part worth checking. Cigna publishes Wegovy benefit exclusion override policies, including EncircleRx versions, that can add limited coverage when that option is part of the plan. The adult weight-loss BMI alternatives are 32 or 35, or 27 with two listed conditions. The existence of a policy does not mean your employer bought it. Sources: Cigna BMI-32 and BMI-35 policies.
So if you hear "excluded," ask one more question: "Does my plan have a weight-loss override, or EncircleRx?"
The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred form (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose. Your plan — not the tool — decides coverage and prior authorization.
What are the Express Scripts Wegovy prior authorization requirements?
Answer: In Cigna's standard Wegovy policy, an adult needs a BMI of 30 or more from before any GLP-1 — or 27 or more with a weight-related health problem — plus at least 3 months of diet and behavior changes. The first approval lasts 8 months. The adult continuation criteria include at least 5% loss from that starting weight, the baseline BMI rules and ongoing diet and behavior changes. Source: Cigna IP0814.
We read Cigna’s Wegovy Injection policy IP0814, which took effect Sept. 1, 2026. It addresses the regular Wegovy pen and Wegovy HD. The Wegovy pill has its own policy, IP0815, with matching adult weight-loss criteria. These documents do not establish which policy your plan uses. Injection policy · Tablet policy
| Rule | In plain words | Proof your doctor sends |
|---|---|---|
| Age | 18 or older (teens have their own rules — see below) | Your chart |
| BMI | 30+ before any GLP-1, or 27+ with 1 health problem from the list below | Your height and weight from before your first GLP-1, with the date |
| Diet and behavior | At least 3 months of trying diet and behavior changes | Visit notes or program records |
| Ongoing plan | Wegovy will be used along with a lower-calorie diet and behavior changes | Your doctor's note |
| No doubling up | Not combined with another GLP-1, such as Ozempic or Mounjaro | Your medication list |
| First approval | 8 months | — |
| Renewal | At least 5% loss, the baseline BMI/condition rules and ongoing diet/behavior changes → 1 year when all continuation criteria are met | Current weight and starting weight, with dates |
BMI is a number based on your height and weight. The height-and-weight chart below shows what the policy thresholds mean in pounds.
The 11 health problems that count at BMI 27
- High blood pressure
- Type 2 diabetes
- High cholesterol or triglycerides (dyslipidemia)
- Obstructive sleep apnea
- Cardiovascular disease
- Coronary artery disease
- Knee osteoarthritis
- Asthma
- COPD (chronic obstructive pulmonary disease)
- Fatty liver disease (MASLD, also called NAFLD)
- PCOS (polycystic ovary syndrome)
It counts if you had it at baseline or have it now. In the stricter BMI 32 and BMI 35 versions, the BMI 27 alternative needs two from this list. Someone who meets the higher BMI threshold does not also need two conditions. Sources: Cigna standard, BMI-32 and BMI-35 policies.
"Baseline" means your weight before your first GLP-1
This rule helps a lot of people. The policy measures your BMI from before you ever started a GLP-1 — not your weight today.
Example (made-up numbers): You're 5'4". You started Wegovy on cash-pay at 205 pounds, a BMI of 35.2. Six months later you weigh 182 pounds, a BMI of 31.2, and your new job's plan covers Wegovy. If a reviewer used 182 pounds, you'd miss the BMI 32 and 35 lines. Using your pre-GLP-1 weight of 205 pounds, you clear all three BMI-only thresholds. That does not settle the rest of the coverage rules.
So find the date and weight from your first GLP-1 visit — even if you paid cash or took a different GLP-1 back then. The policy's own examples of earlier GLP-1s include Saxenda, Wegovy and Zepbound. Source: Cigna IP0814.
Already on Wegovy for 8 months or more?
The policy has a second set of questions for people "currently receiving" Wegovy — the pen, HD or pill — after 8 months of treatment. That set asks for at least 5% weight loss from your pre-GLP-1 weight. It doesn't repeat the 3-month diet trial, but it does keep the baseline BMI/condition rules and ongoing diet and behavior requirements. Source: Cigna IP0814.
If you've been on Wegovy that long, even on cash-pay, ask your doctor which set of questions fits you. Bring both weights with dates. The reviewer makes the final call.
What counts as "3 months of diet changes"?
The policy asks for at least 3 months of trying diet and behavior changes. It doesn't name a program.
Our advice: make sure your chart shows it. That means visit notes over at least 3 months that mention your eating and activity plan. If you used a dietitian, an app or a work wellness program, keep those records too.
Do you have to try another weight-loss drug first?
Not in the adult weight-loss sections of the Cigna Wegovy policies we read. They ask for diet and behavior changes, not a trial of another drug. Your plan could add its own step rule, so ask. (TRICARE uses different forms and rules — see below.) Sources: Cigna standard and override policies.
Wegovy pill and Wegovy HD: same rules?
For adult weight loss, the standard Cigna tablet and injection policies use matching baseline BMI, diet/behavior and approval-duration rules. That does not make the products interchangeable. Sources: Cigna IP0814 and IP0815.
- Wegovy pill (tablets): its own policy, with the same adult weight-loss rules and the same 8-month first approval.
- Wegovy HD (7.2 mg): addressed in the injection policy. Its labeled use is adult weight loss after tolerating 2.4 mg weekly for at least 4 weeks, when more weight reduction is clinically needed. It is not a starting dose or the labeled pediatric maintenance dose.
- Switching: the policies can count prior Wegovy pill and injection treatment toward continuation history. Do not assume an existing PA automatically covers a different form or dose; have the office check the new prescription.
Sources: Cigna injection policy and Wegovy prescribing information.
A published Cigna policy is not proof that the product is covered under your own Express Scripts benefit. Ask about the exact product, dose and treatment use before changing pharmacies or paying for another appointment.
More help: GLP-1 BMI eligibility chart · Obesity ICD-10 codes for GLP-1 prior authorization. Your clinician must use the diagnosis your records support; a code is not a coverage shortcut.
Which Express Scripts Wegovy rules apply to you?
Answer: Ask for the policy name or number attached to your benefit. The Cigna documents below use three adult weight-loss BMI patterns — 30, 32 or 35, with different alternatives at BMI 27. Your Express Scripts card alone does not identify the right row. TRICARE, Medicare Part D and the Medicare GLP-1 Bridge have separate rules. Sources: Cigna policy index and CMS.
Same drug. Same benefit manager. Different plan rules. That’s how two people with Express Scripts cards can get different answers.
The Express Scripts Wegovy rule chart
Our comparison: selected published policies, not a lookup of your personal benefit. All rows have additional requirements. The BMI column shows only the BMI part of the rule.
| Published policy or treatment use | BMI part of the rule | Other key requirements | Initial approval → continuation |
|---|---|---|---|
| Standard adult weight loss: IP0814; CNF1010 | Baseline BMI 30+, or 27+ with 1 listed condition | 3 months of diet/behavior changes; ongoing diet/behavior plan | 8 months → 1 year if all continuation criteria, including at least 5% loss, are met |
| BMI-32 adult override: BEO008; CNF1019 | Baseline BMI 32+, or 27+ with 2 listed conditions | 3-month trial; check documentation rules. BEO008 also requires participation in the plan’s lifestyle program | 8 months → 1 year if all continuation criteria, including at least 5% loss, are met |
| BMI-35 adult override: BEO012; CNF1020 | Baseline BMI 35+, or 27+ with 2 listed conditions | 3-month trial; check documentation rules | 8 months → 1 year if all continuation criteria, including at least 5% loss, are met |
| Adult cardiovascular-risk reduction: IP0814 | Baseline BMI 27+ and the specified history of heart attack, stroke or symptomatic PAD | Appropriate heart medicines; diet/behavior plan | 1 year → 1 year; no 5% weight-loss test listed |
| Adult MASH with F2–F3 scarring: IP0814 | No separate BMI cutoff in this section | Noncirrhotic disease, qualifying tests, a managed metabolic risk, alcohol limits and specialist involvement | 1 year → 1 year under the MASH continuation criteria |
| Weight loss, ages 12–17: IP0814 | Pretreatment BMI at or above the 95th percentile for age and sex | 3-month lifestyle trial; ongoing diet/behavior plan; use the pediatric injection regimen | 8 months → 1 year under pediatric continuation criteria, including at least a 1% BMI reduction |
IP0814, BEO008 and BEO012 took effect Sept. 1, 2026. CNF1010, CNF1019 and CNF1020 were reviewed June 17, 2026. The standard tablet documents are IP0815 and CNF1009. Your plan could use one of these documents or its own rules. For government coverage, use the TRICARE and Medicare section, not this table.
Cigna’s BMI-32 and BMI-35 override policies say their adult BMI thresholds are “not based on clinical data.” They exist so a subset of patients can get coverage through that benefit option. In plain words: these particular cutoffs are benefit rules, not treatment advice. Sources: BEO008 and BEO012.
Did you cross the line? BMI by height
Before your first GLP-1, did you weigh at least this much? (Pounds, rounded up.) This checks a BMI threshold only — not the full policy.
| Height | BMI 27 | BMI 30 | BMI 32 | BMI 35 |
|---|---|---|---|---|
| 5'2" | 148 | 165 | 175 | 192 |
| 5'4" | 158 | 175 | 187 | 204 |
| 5'6" | 168 | 186 | 199 | 217 |
| 5'8" | 178 | 198 | 211 | 231 |
| 5'10" | 189 | 210 | 224 | 244 |
| 6'0" | 200 | 222 | 236 | 259 |
Our math: BMI = 703 × weight in pounds ÷ (height in inches × height in inches). Your plan uses the exact numbers in your chart.
The weight-app rule some plans add
Cigna’s current BMI-32 injection override policy BEO008, effective Sept. 1, 2026, requires enrollment in the plan’s lifestyle program and at least 4 weigh-ins and 4 app engagements every month. The policy lists several types of app activity. These are two requirements, not necessarily eight separate visits. Source: Cigna BEO008.
If that program rule applies to your benefit, the right BMI alone is not enough. Do not apply BEO008’s app rule to every policy with a BMI-32 threshold.
What should you ask Express Scripts to find your version?
Call the number on the back of your Express Scripts card. Ask:
- "Does my plan cover weight-loss medicines?"
- "Is Wegovy — the pen, HD or pill — covered, and does it need a coverage review?"
- "What is the name or number of my Wegovy policy? What baseline BMI and health-condition rules apply to this treatment use?"
- "Do I have to join a lifestyle program or app?"
- "Is my plan in Express Scripts' $200 monthly cap program?"
- "Is a prior authorization on file? What's the status and the reference number?"
Write down the date, the rep's name and the reference number. If the rep can't answer question 3, your doctor's office can ask Express Scripts for the exact criteria. Evernorth says it shares prior authorization criteria when asked. Source: Evernorth.
Past heart attack, stroke or PAD? There's a separate path
Wegovy is also FDA-approved to lower the risk of heart attack, stroke and cardiovascular death in adults with established cardiovascular disease and obesity or overweight. Source: Wegovy prescribing information.
In Cigna's policies, that path needs a BMI of 27 or more before any GLP-1, plus one of these:
- A past heart attack
- A past stroke (a TIA, or "mini-stroke," doesn't count)
- Symptomatic peripheral artery disease (PAD) with the evidence the policy specifies: leg symptoms plus an ankle-brachial index below 0.85, a prior procedure to restore blood flow in a peripheral artery, or amputation due to atherosclerotic artery disease
Approval lasts a year, and no 5% weight-loss test is listed. The policy also requires appropriate treatment of the heart condition and ongoing diet and behavior changes. This path applies only if it's true and in your records. It isn't a box to pick. Source: Cigna IP0814, cardiovascular criteria.
Fatty-liver scarring (MASH) and teens
MASH is a serious fatty liver disease. Wegovy injection has accelerated FDA approval for adults with noncirrhotic MASH and moderate to advanced scarring, stage F2 to F3. Continued approval depends on confirming clinical benefit in a trial. This use is not on the Wegovy tablet label. Source: prescribing information.
In Cigna IP0814, the liver evidence must be a qualifying biopsy from within 3 years before treatment, or specified noninvasive testing from within 6 months. The noninvasive options are liver-stiffness testing called VCTE or MRE, or an ELF blood-test score of 9.2–10.5. A liver, GI or hormone specialist must be involved. The policy also requires management of a listed metabolic risk — central obesity, high triglycerides, low HDL cholesterol, high blood pressure or elevated blood sugar — plus diet/exercise changes. Its alcohol limits are under 20 grams daily for females and under 30 grams for males, as defined in the policy. A generic “fatty liver” note does not establish these requirements. Continuation requires at least 1 year of treatment without worsening fibrosis or MASH, no cirrhosis, and the ongoing care requirements. Source: Cigna IP0814, MASH criteria.
Teens 12 to 17 have a separate injection section in IP0814. Initial criteria include a pretreatment BMI at or above the 95th percentile for age and sex and 3 months of lifestyle changes. Pediatric continuation requires at least a 1% BMI reduction plus the other criteria; that section directs patients with less than 7 months of initial therapy to the initial criteria. The pill and HD 7.2 mg are not the labeled pediatric treatment options. Cigna policy · FDA-approved label
Use the Express Scripts Wegovy PA worksheet
Copy these six lines into a note, or print this section. Fill in only what you can confirm. “Not sure” is a useful answer — it tells you what to ask next.
| Write down | What you need |
|---|---|
| 1. My benefit | Job/union plan, Cigna plan, TRICARE or Medicare; the policy name/number supplied by the plan |
| 2. My prescription | Wegovy pen, HD or tablet; dose; the treatment use your clinician documented |
| 3. My request | Not filed, pending, denied or renewing; case number; submission date; missing information |
| 4. My records | Dated height and weight from before the first GLP-1; current measurements; relevant conditions already in the chart |
| 5. My policy requirements | Diet/behavior records and any plan-specific lifestyle program; identify the exact missing item |
| 6. My next action | Person to contact, question to ask, and actual deadline from the case or approval letter |
Use the call script above, doctor message below and renewal math to fill the gaps. Your approval letter supplies the expiration date; do not calculate it simply by adding 8 months to your first dose.
This is a preparation worksheet, not an insurance eligibility check. It cannot identify your policy or predict approval. Keep personal records in your own notes and send medical documents only through your clinician’s or plan’s secure channel.
Rather have someone else call your plan? Ro’s free GLP-1 Insurance Coverage Checker has its insurance team contact your plan and email you a report on supported products, including the Wegovy pen. The report includes PA requirements and an estimated copay. It does not file a PA, write a prescription or check the Wegovy pill. New accounts can receive a $50 Ro credit — not a cash payment. Source: Ro’s checker page.
▶ Get my free Wegovy pen coverage report
Ro’s official free checker. It requires your information so Ro can contact your plan and send the report; it is separate from the worksheet above.
How does your doctor submit an Express Scripts Wegovy prior authorization?
Answer: Your doctor’s office supplies the clinical answers. It can use electronic prior authorization through CoverMyMeds, Surescripts or Evernorth’s EviCore prescription-drug portal. Evernorth also lists 800-753-2851 for prescriber assistance; some plans have their own contact instructions. You can help start the process and track it, but you cannot replace the prescriber’s medical answers. Source: Evernorth.
Electronic prior authorization (ePA) means the office answers your plan’s questions online instead of faxing pages and hoping. Evernorth says more than half of its monthly requests arrive electronically. Some electronic requests can be decided within minutes; that is not a promise for every request. Sources: Evernorth and Express Scripts.
| How offices file | Who uses it | What to know |
|---|---|---|
| CoverMyMeds, Surescripts or EviCore’s prescription-drug portal | Prescriber’s office | Use the workflow for this pharmacy benefit. Save the submission confirmation. |
| Phone: 800-753-2851 | Prescriber’s office | Evernorth’s listed PA assistance line; use a plan-specific number when directed. |
| Fax | Prescriber’s office | Use the current form and destination supplied for the plan. Keep the transmission confirmation. |
| TRICARE | TRICARE-authorized prescriber | Get the current drug-specific form from the TRICARE Formulary Search tool. Commercial Cigna PDFs are not TRICARE forms. |
The fax trap (a real story)
In a public complaint from November 2023, an Express Scripts member named Jam Riley, of Oklahoma City, described two months of trying to get Wegovy approved. Jam reported repeated disputes over whether faxed paperwork had arrived, followed by a request through CoverMyMeds. This is one person’s account, not a finding about typical processing times. Source: the dated complaint.
In Jam's words: "I am in the middle, trying to resolve this." Source.
The fix is boring but powerful: ask for electronic filing, and ask for the date and a reference number.
The doctor packet: what to bring
| Bring this | Why the reviewer wants it | Where to find it |
|---|---|---|
| Height and weight from before your first GLP-1, with the date | The compared weight-loss policies use pre-GLP-1 baseline BMI | Old visit notes; your first GLP-1 visit |
| Current weight, with the date | Needed for renewals; shows progress | A recent visit |
| Your health problems from the list | The BMI 27 door needs 1 (or 2 in stricter plans) | Your chart's problem list |
| At least 3 months of diet and behavior notes | Required for initial adult weight-loss requests in the compared policies; other uses and continuation have different requirements | Visit notes; program records |
| Every GLP-1 you've taken, with dates | Confirms your baseline; shows no overlap | Pharmacy history |
| The exact product and dose (pen, HD 7.2 mg or pill) | The office must submit the exact prescribed product | Your prescription |
| Weight-app proof, if your plan requires it | BEO008 requires 4 weigh-ins + 4 app engagements monthly when that policy applies | App screenshots |
| Heart path: records of a heart attack, stroke or PAD | A different set of rules | Hospital or specialist records |
Copy this message to your doctor's office
Hi — my pharmacy says Wegovy needs a prior authorization through Express Scripts. Could you file it electronically? CoverMyMeds and Surescripts both work for Express Scripts. Please tell me which records you need and where I should send them securely. I can help find my dated pre-GLP-1 measurements, treatment history, diet/behavior notes and recorded health conditions. Could you confirm the policy and whether this should be an initial or continuation request? Once it's sent, could you tell me the date and the reference number? If Express Scripts asks for more information, please let me know what they need.
What if your doctor's office won't handle the paperwork?
Answer: You can push your current office to file electronically, or use a telehealth program whose team files the prior authorization for you. Ro's insurance concierge handles prior authorization paperwork for the Wegovy pen as part of its membership, but paid help can't guarantee that Express Scripts will approve Wegovy.
First, the honest part. If your doctor's office already filed and is following up, you don't need to pay anyone. Send the message above and use the status steps below.
But some offices don't do prior authorizations. Some are too busy. And some requests die in a fax machine. If that's you, Ro is where we'd look first for the Wegovy pen. Here's exactly what it does — and doesn't do. This is our fit judgment based on its published service, not a claim that Ro wins more approvals.
| What you want to know | Ro’s published answer, checked Sept. 22, 2026 | What that does not prove |
|---|---|---|
| Who files the PA? | Its insurance concierge checks benefits and handles paperwork after a Ro-affiliated provider prescribes | It does not promise to take over a prescription from an outside clinician without its own evaluation |
| Which products get insurance help? | Wegovy pen, Zepbound autoinjector pen and Ozempic | The Wegovy pill is not included in the listed insurance-support products; confirm HD 7.2 mg directly |
| How long? | Ro describes its insurance process as typically 1–3 weeks | That includes more than Express Scripts’ review after complete information arrives |
| Membership cost | $39 first month; then $149 month to month, or as low as $74/month with an annual plan paid upfront | The $74 figure is a prepaid-plan equivalent, not monthly billing |
| Refund | Ro says it refunds the $39 if you are not clinically eligible for GLP-1 treatment | An insurance denial is not the same as clinical ineligibility |
| Medication included? | No. Your copay or cash medication price is separate | Membership does not pay for the drug |
| Government plans? | Certain Medicare/TRICARE cash-pay options; FEHB can use the concierge | Ro says Medicaid and some other government-funded plan members are not eligible for its treatment program |
Verified against Ro’s insurance page and pricing page. These are provider-stated services and terms, not our test of Ro’s performance.
The one catch: Ro does NOT list the Wegovy pill among the products it runs through insurance. If getting the pill covered is your priority, Sesame is an option to compare: it offers Wegovy pills and its weight-loss providers offer PA help. Ask the chosen clinician about your exact pill request before paying. Ro’s published insurance list does not resolve HD 7.2 mg separately, so confirm that product directly. Ro insurance support · Sesame Wegovy options
But if you’re prescribed the Wegovy pen through Ro, its concierge handles the part that got Jam stuck — the paperwork and the follow-up. And if Express Scripts says no, Ro can discuss FDA-approved cash-pay options if they fit your care. Paid help cannot make an excluded benefit covered. Source: Ro.
"Ro has been invaluable." — a member quoted in Ro’s 2025 GLP-1 Insurance Coverage Checker report. Ro chose and published this quote. We may earn a commission from Ro links. Experiences vary.
Does that sound like your situation — a Wegovy pen prescription, and nobody chasing the paperwork?
Explore Ro's Wegovy care and PA support (sponsored) Get started for $39, then as low as $74/month with annual plan paid upfront ($149 month to month). Medication billed separately. Ro states that the $39 is refunded for clinical ineligibility, not simply because insurance says no.
Need the Wegovy pill covered instead? See Sesame's clinicians and Wegovy care options → (sponsored) Sesame’s program starts at $99 per 28-day billing cycle, or a $59/month equivalent on an annual plan paid upfront. Medication costs extra; provider prices can differ. Source: Sesame’s program terms.
Want to compare more options? See GLP-1 providers that work with Express Scripts.
How long does Express Scripts take to approve Wegovy?
Answer: Express Scripts says nearly all coverage reviews are finished within two days after it gets complete information from your doctor, and some electronic requests can be decided within minutes. That two-day estimate starts when the information is complete — not when your prescription was written. It is an estimate for a review, not a guarantee of approval. Source: Express Scripts.
So if it's been a week, don't just wait. Find out whether Express Scripts has a complete request.
| Step | Who handles it | What to check |
|---|---|---|
| Pharmacy flags the PA | Pharmacy and your doctor | Has anyone actually sent a coverage-review request? |
| Doctor submits it | Doctor’s office | Submission date, destination and case number |
| Plan reviews it | Express Scripts for your plan | Is it complete? What is the decision deadline for this case? |
| Pharmacy fills it | Pharmacy | Has the approval posted, and can the pharmacy rerun the claim? |
| You challenge a denial | You, your doctor and the plan | Follow the applicable appeal process and keep proof of submission |
The legal clock is different from the two-day estimate. For many private job-based plans covered by ERISA, a pre-service claim must be decided within 15 calendar days after receipt. A permitted extension can add up to 15 days, with required notice. Requests for missing information can pause parts of the clock; the plan generally must give at least 45 days to provide that information. Urgent claims generally require a decision within 72 hours, with separate missing-information rules. Source: U.S. Department of Labor.
For those plans, a first internal appeal generally allows at least 180 days to file. A pre-service appeal decision is generally due within 30 days for one appeal level, or 15 days per level when there are two; urgent appeals generally take no more than 72 hours. Government and church plans can have different rules, and state law may give additional rights. See the appeal section for external review. Source: Department of Labor.
Use the instructions in your letter, but do not assume a shorter stated deadline can cancel a legal right. For help with a private job-based plan, contact the Department of Labor’s benefits advisers at 1-866-444-3272. Source.
How to check your Express Scripts prior authorization status
- Log in at express-scripts.com or open the Express Scripts app.
- Go to Prescriptions → Prior Authorizations.
- Look for approved, denied or withdrawn.
A withdrawn request closed without an approval or denial. Ask your doctor's office what happened and whether to refile. Source: Express Scripts.
▶ Open my Express Scripts prior authorization status (Official Express Scripts site — not an affiliate link)
When to call, and what to say
Our follow-up checkpoint: if the office says it filed but nothing shows up after 3 business days, call the number on your card and ask. You can check sooner; this is not an Express Scripts waiting rule:
- "Is there a prior authorization on file for Wegovy?"
- "What date did you receive it?"
- "Is anything missing from my doctor?"
- "What's the reference number?"
Need it sooner?
Express Scripts lists these general options when a medicine is needed quickly. For Wegovy, ask the pharmacist which are actually possible for the prescribed product:
- Ask your pharmacist about a small supply now (you may pay full price).
- Ask your doctor to request faster processing, if your doctor thinks it's urgent.
- Ask your doctor about a covered alternative.
- Fill it at full price.
Faster processing is for real medical urgency, and your doctor makes that call. A small supply is not always available for a packaged injection. If doses are missed, ask your prescriber how to restart; do not double up or change the dose to bridge the gap. Express Scripts urgent options · Wegovy label
Why did Express Scripts deny my Wegovy, and how do you fix it?
Answer: Start with the reason in your letter. Missing information, a clinical-criteria denial, a benefit exclusion and a pharmacy claim rejection need different responses. A corrected request or appeal can address some problems, but neither guarantees coverage. Source: Express Scripts’ appeal guidance.
Read the reason before you do anything else. Express Scripts says your denial letter explains your appeal rights and how to file. Then find your reason below.
| What the letter or pharmacy says | What to check — not assume | Next step | Who acts |
|---|---|---|---|
| “Lack of information” or “incomplete” | Which exact answer or record is missing? | Ask whether to complete the existing case, resubmit or appeal; preserve any appeal deadline | Doctor |
| “Withdrawn” | Why was the request closed? | Ask whether a new submission is needed; withdrawal is not a clinical denial | Doctor |
| “Does not meet criteria” or “medical necessity” | Which policy and criterion did the review apply? | Compare that criterion with the actual records; correct or appeal as appropriate | Doctor + you |
| BMI “doesn’t qualify” after weight loss | Was the right pretreatment baseline used? | Send the dated pre-GLP-1 measurements if the applicable policy uses that baseline | Doctor |
| “Not a covered benefit” or “excluded” | Is this use excluded, and is an override or exception available? | Ask about that specific process before buying more PA help | You + plan |
| “Not preferred” or “non-formulary” | Is this exact product on your plan’s drug list? | Ask about a formulary exception or a clinically suitable covered product | Doctor + plan |
| “Refill too soon” or “quantity limit” | Is this a timing limit, dose issue or supply limit? | Ask the pharmacist for the exact rejection and whether an override is available | Pharmacy + doctor |
| “Authorization expired” | Which approval expired, and what are its continuation rules? | Submit the correct renewal evidence for weight loss, cardiovascular risk or MASH | Doctor |
| “Duplicate therapy” | Is another GLP-1 still active in the records? | Have the clinician reconcile the medication list and treatment plan | Doctor |
| “Program requirement not met” | Which program and activity requirements apply? | Address the actual rule; BEO008’s 4 weigh-ins and 4 app engagements are one example, not every plan’s rule | You + program |
Our decision table combines Express Scripts’ process guidance with the named Cigna policies. It does not infer why a particular person was denied.
How to appeal an Express Scripts Wegovy denial
- Find the reason and the deadline on your letter.
- Match the reason to the table above.
- Fix the documented gap: baseline weight, health conditions, initial diet/behavior notes or any required program proof. Do not add a diagnosis your records do not support.
- Ask your doctor for a short letter that answers each rule, in order.
- Send it where the letter says. Keep proof that you sent it.
- Ask whether a doctor-to-doctor review is available.
- If you’re denied again, ask whether the decision qualifies for external review — review by an independent party outside your plan.
For many private job-based plans, you get at least 180 days for the first internal appeal. External review is not available for every denial; eligible disputes commonly involve medical judgment, experimental treatment or cancellation of coverage. A pure benefit exclusion may not qualify. The federal external-review process generally gives 4 months after the relevant denial notice to request review, with decisions generally within 45 days or within 72 hours for urgent reviews. State procedures can differ. Department of Labor · HealthCare.gov external-review rules
A date-specific exception: HealthCare.gov says requests under the HHS-administered federal external-review process whose original deadlines fell from July 1 through Aug. 3, 2026, can be filed through Oct. 2, 2026. This is not an extension for every insurance appeal. Ask which external-review process your plan uses. Source: HealthCare.gov.
Tools that help: GLP-1 insurance appeal letter template · Why did my insurance deny Wegovy?.
What a real Wegovy case shows: public record, another payer
New York, 2022: in a state external appeal involving a CVS Caremark self-funded plan, a reviewer overturned a Wegovy renewal denial. The records showed a starting weight of 174 pounds and 141 pounds on treatment, against a plan rule that required at least 5% loss. That was a 33-pound loss, about 19%. This was one decision under another plan, not a prediction for an Express Scripts appeal. New York DFS case 202208-152420.
The practical lesson: make every number match — the form, the chart note and your appeal letter.
Why we don’t print an approval rate: We did not verify a representative national Express Scripts Wegovy approval rate. Evernorth links state-required PA reports, but those do not establish a single national Wegovy rate. A percentage from another payer, a provider’s patients or a selected state report would not tell you your chance of approval. Source: Evernorth’s reporting links.
How long does an Express Scripts Wegovy approval last?
Answer: In the compared Cigna weight-loss policies, initial approval is 8 months and continuation approval is 1 year when the full criteria are met. Adults need at least 5% loss from their pre-GLP-1 weight; teens need at least a 1% BMI reduction. The cardiovascular and MASH sections use different continuation tests. Your own approval notice gives your actual end date. Source: Cigna IP0814.
| Weight before your first GLP-1 | 5% of that | Weight at the 5% threshold |
|---|---|---|
| 200 lb | 10 lb | 190 lb |
| 220 lb | 11 lb | 209 lb |
| 240 lb | 12 lb | 228 lb |
| 260 lb | 13 lb | 247 lb |
| 280 lb | 14 lb | 266 lb |
| 300 lb | 15 lb | 285 lb |
Our math: percent lost = (starting weight − current weight) ÷ starting weight × 100. This shows the policy's line. It doesn't decide coverage or whether treatment should continue — your doctor and your plan do.
Renew before your approval ends
Express Scripts says that if a renewal is approved before your current approval expires, your plan keeps covering Wegovy without a gap. Source: Express Scripts.
Our planning tip — not an insurer’s filing deadline:
- About 6–8 weeks before the end date on your approval: ask what records and visit are needed.
- Before the current approval ends: have the office confirm when the plan accepts continuation requests and whether the required treatment period is complete. Get the measurements into your chart and save the submission reference.
Short of 5%?
The adult weight-loss continuation sections we compared do not list an automatic exception to the 5% requirement. Check your full weight history first — sometimes the loss happened but never made it into your chart. If the numbers truly fall short, talk with your doctor about your options and your treatment path. Don't change your dose to hit a number on a form.
Need to check the request type? See the initial-versus-continuation rules above.
How much will Wegovy cost with Express Scripts after approval?
Answer: You pay the patient share set by your plan. Eligible patients with commercial insurance that covers Wegovy can use Novo Nordisk’s Savings Offer for a price as little as $25, with a maximum saving of $100 per monthly fill. It is not a promise of a $25 copay for everyone. An optional Evernorth benefit can cap the member price at $200 when the plan has adopted it. Novo offer terms · Evernorth benefit announcement
| Your cost before savings | Illustrative cost after eligible savings |
|---|---|
| $50 | $25 |
| $125 | $25 |
| $300 | $200 |
| $700 during a deductible | $600 |
Our examples apply the current $100 maximum saving to eligible claims. “As little as $25” is not a rule that raises a lower existing copay to $25. If your usual cost is already below $25, have the pharmacy confirm the actual amount; do not pay more because of this table. Offer terms.
Rule of thumb: for an eligible claim with a patient cost above $25, the offer can bring it down toward $25, but saves no more than $100 per monthly fill. Enroll by texting SAVE to 83757 or through NovoCare before the fill. Medicare, Medicaid and TRICARE members cannot use this commercial-insurance copay offer. Separate cash-pay terms are different. Savings enrollment · Terms
Using Express Scripts home delivery? Your savings card may not work there
Express Scripts Pharmacy, its home delivery service, can’t accept manufacturer coupons at checkout. Express Scripts says you may be able to use the discount at a network retail pharmacy instead, and it suggests checking its Price a Medication tool first. If your plan requires home delivery for Wegovy, ask before you switch pharmacies. Source: Express Scripts.
There is one more option to check: Novo’s terms describe a reimbursement process for eligible mail-order fills or pharmacies that cannot process the card. You must be enrolled before the fill, and the claim must be submitted within 180 days. Novo says processing can take 6–8 weeks. Ask Novo whether your fill qualifies before relying on a refund; keep the required receipts and card details. Official terms and reimbursement instructions.
The $200 cap: only if your plan has the benefit
In May 2025, Evernorth announced a benefit that caps member costs for Wegovy and Zepbound at no more than $200 a month for plans that sign up. The announcement says the payment counts toward the deductible, comes with a simpler PA process, and is available at retail pharmacies or through EnGuide home delivery. That announcement does not establish your plan’s current participation. Source: Evernorth.
Your employer has to opt in. Ask HR or Express Scripts whether your plan has it.
More: Wegovy savings card rules · GLP-1 providers for Express Scripts.
Is it different on TRICARE or Medicare?
Answer: Yes. TRICARE uses its own benefit rules and forms; its eligible plan list is broader than just Prime and Select. Medicare Part D does not cover drugs used only for weight loss, while the separate Medicare GLP-1 Bridge offers eligible Part D members a $50 fill from July 1, 2026, through Dec. 31, 2027. Humana processes Bridge claims, not Express Scripts. TRICARE · CMS
TRICARE
TRICARE’s current list includes Prime, Prime Remote, US Family Health Plan, Select, Young Adult, Reserve Select, Retired Reserve and the Continued Health Care Benefit Program. You must meet the clinical criteria and use the required prescriber and PA process. Do not rule out Reserve Select or another listed plan just because its name is not “Prime” or “Select.” Source: TRICARE, updated Aug. 6, 2026.
Weight-loss drugs are not covered for TRICARE For Life, direct-care-only beneficiaries and certain other excluded groups. The weight-loss benefit change took effect Aug. 31, 2025. An earlier PA does not create an excluded benefit. Coverage for a different medically supported use requires its own check. TRICARE · Express Scripts TRICARE FAQ
Forms: find the current drug-specific form through the TRICARE Formulary Search tool. Follow the form’s prescriber contact and submission instructions rather than a commercial Cigna policy PDF.
Full guide: TRICARE Wegovy prior authorization.
Medicare Part D or Medicare GLP-1 Bridge?
First identify the prescribed use. A Part D-eligible use, such as qualifying cardiovascular-risk reduction or MASH treatment, goes through the Part D plan’s rules. The Bridge is a separate program for eligible weight-management treatment; it is not a general replacement for Part D coverage. Source: CMS.
| Bridge question | CMS’s published rule |
|---|---|
| Who can use it? | Adults 18+ enrolled in an eligible Part D plan who meet the clinical criteria and participate in structured nutrition and physical-activity support |
| BMI and conditions | At GLP-1 treatment initiation: BMI 35+; or BMI 30+ with heart failure with preserved ejection fraction (HFpEF), specified uncontrolled hypertension or stage 3a+ kidney disease; or BMI 27+ with prediabetes, a past heart attack, a past stroke or symptomatic PAD |
| What does “uncontrolled hypertension” mean here? | Systolic pressure above 140 or diastolic above 90 despite two blood-pressure medicines |
| What does it cost? | $50 per eligible monthly fill. It does not count toward Part D out-of-pocket costs, and coupons cannot be used |
| Which products are listed? | Wegovy injections, including HD, and tablets; Foundayo; and Zepbound KwikPen |
| Who processes it? | Humana, outside the normal Part D claim flow |
| What happens first? | The pharmacy submits the Bridge claim to establish eligibility, then the prescriber submits the PA |
| Decision and duration | CMS states a decision within 72 hours of submission; approvals run through Dec. 31, 2027 |
| Can you appeal? | The Bridge has no appeals process. A prescriber can resubmit with corrected or additional information |
Source: CMS Bridge pharmacy and provider instructions. The clinical criteria are program rules, not permission to select a diagnosis for coverage. A past heart event does not automatically make the Bridge the right process when the prescribed use belongs under Part D.
One twist: CMS directs patients with type 2 diabetes, moderate to severe obstructive sleep apnea, or noncirrhotic MASH to Part D-eligible treatment pathways rather than the Bridge. That does not guarantee your Part D plan approves a particular drug. Source: CMS.
Full guides: Medicare GLP-1 Bridge · Bridge application process.
What if Express Scripts won't cover Wegovy at all?
Answer: You can still get FDA-approved Wegovy without insurance if a clinician prescribes it and you meet the purchase program’s terms. NovoCare’s current pen offer is $199 per eligible starter fill for the first two fills, then $349 for doses through 2.4 mg. Wegovy tablets start at $149 for the 1.5 mg strength; the 25 mg maintenance strength is $299. Telehealth care fees are extra. Source: Novo Nordisk.
Here’s what the cash options cost, checked Sept. 22, 2026. Injection prices cover four weekly pens, or 28 days; tablet prices cover 30 tablets. Those are not identical calendar-month supplies.
| Where | Wegovy medication price | Extra care or membership cost | Best fit — our judgment | We earn? |
|---|---|---|---|---|
| NovoCare Pharmacy | Pen: $199 for the first 2 eligible 0.25 or 0.5 mg fills through Dec. 31, 2026; then $349 through 2.4 mg. HD 7.2 mg: $399. Pill: $149 at 1.5 mg, $199 at 4 mg, $299 at 9 or 25 mg | No NovoCare care-membership fee; your existing clinician can still charge for care | You already have a prescription and follow-up care | No |
| Ro | Ro publishes manufacturer-program cash prices, subject to the same product and offer limits | $39 first month, then $149 month to month or as low as $74/month with annual prepay | You need a prescriber, ongoing care and help exploring insurance plus a cash backup | Yes, through labeled affiliate links |
| Sesame | Advertises Wegovy pill from $149 and pen access under manufacturer offers; use Novo’s current dose-specific terms above | From $99 per 28-day billing cycle, or a $59/month equivalent with annual prepay; provider prices vary | You want to choose a clinician or ask about Wegovy pill PA help | Yes, through labeled affiliate links |
| Costco Pharmacy’s member program | Current member self-pay offers include pen starter fills from $199, then $349; pill prices from $149, with strength-specific pricing | Costco membership for the stated member offer. A Sesame subscription is not required when your own clinician sends the prescription | You have a prescription and want to use Costco’s eligible member pricing | No pharmacy commission claimed here |
Primary sources: Novo’s current terms and price guide, Ro pricing, Sesame’s program, and Costco’s Member Prescription Program. “New” eligibility for the pen intro offer refers to the applicable savings-program terms, not simply whether you have ever taken Wegovy. The former $149 promotion for the 4 mg tablet ended Aug. 31, 2026; its current listed price is $199.
The number to budget is medicine plus care. For example, Ro’s $149 starter tablet plus the $39 introductory care fee totals $188. A $299 tablet fill plus the $149 month-to-month care fee totals $448. Those are our sums of the published charges, not a promise of clinical eligibility or an annual total; prepaid care has a different payment schedule. Ro pricing · Novo prices
What about compounded semaglutide? It is not FDA-approved, and it is not the same product as Wegovy. This page is about getting FDA-approved Wegovy covered. FDA says compounded drugs are for patients whose medical needs cannot be met by an approved drug. If you’re weighing compounded options, read our side-by-side comparison first. Source: FDA.
If your plan won’t pay, a qualifying cash purchase lets you skip the insurance PA — not the prescription or clinical evaluation. Novo’s cash-program terms also prohibit submitting that purchase to insurance for reimbursement or deductible credit. Source: Novo.
Explore Ro's FDA-approved Wegovy care and cash-pay options (sponsored)
The $149 starting medication price is for the 1.5 mg tablet, not every dose. Ro membership is extra: $39 initially, then $149 month to month or as low as $74/month with annual prepay.
Already have a prescription? NovoCare Pharmacy sells the same medication with no care membership. We earn nothing on that. Costco member? Your own prescriber can send the prescription to Costco; Sesame is an optional way to obtain care, not a required pharmacy fee. Costco’s program · Sesame’s explanation
More: Cheapest Wegovy without insurance · Wegovy pill cost without insurance · NovoCare GLP-1 prices and rules.
How we checked this page
Answer: We read Express Scripts’, Cigna’s, Novo Nordisk’s, TRICARE’s and CMS’s own documents and recorded the policy dates and purchase terms, most recently on Sept. 22, 2026. We did not access anyone’s insurance account, file a PA or measure approval rates. Where we couldn’t see something — like your employer’s exact version — we say so.
| Source | Document or page | Document date or verification date | What it supports |
|---|---|---|---|
| Cigna | IP0814 injection and IP0815 tablet | Effective Sept. 1, 2026 | Standard criteria, continuation, form-specific policy details |
| Cigna | BEO008 BMI-32 override and BEO012 BMI-35 override | Effective Sept. 1, 2026 | Higher-threshold benefit designs; BEO008 program rule |
| Cigna | CNF1010, CNF1009, CNF1019, CNF1020 | Reviewed June 17, 2026 | Related national-formulary policy comparisons |
| Express Scripts | PA FAQs, timing, coupon FAQ | Checked Sept. 22, 2026 | Submission, status, review estimate and home-delivery coupon limit |
| Evernorth | PA resources; optional $200 benefit | Checked Sept. 22, 2026; benefit announced May 21, 2025 | Prescriber channels, criteria access, AI statement, optional benefit |
| Novo Nordisk | Savings terms, price guide, prescribing information | Checked Sept. 22, 2026; label revised June 2026 | Dose prices, eligibility, reimbursement and labeled uses/safety |
| Ro | Pricing, insurance, free checker | Checked Sept. 22, 2026 | Published costs, support scope, refund and checker limits |
| Sesame and Costco | Sesame program, Wegovy page, Costco member program | Checked Sept. 22, 2026 | Care billing, PA help and independent pharmacy access |
| TRICARE | Coverage FAQ; Express Scripts TRICARE FAQ | TRICARE updated Aug. 6, 2026; checked Sept. 22 | Eligible plans, excluded groups and form routing |
| CMS | Bridge pharmacy and provider instructions | Checked Sept. 22, 2026 | Eligibility, processor, $50 cost, claim order and no-appeal rule |
| Department of Labor; HealthCare.gov | Claims/appeals guidance; external review | Checked Sept. 22, 2026 | Applicable deadlines, limits and the narrow October 2026 extension |
| KFF; New York DFS | 2025 employer survey; case 202208-152420 | Survey: 2025; case: 2022 | Precisely scoped coverage statistic and one historical appeal |
Provider-stated versus independently checked
| Item | What we actually did | What we do not claim |
|---|---|---|
| Prices and program scope | Read the providers’ current public pages and terms | A completed checkout, enrollment or personal coverage check |
| Insurance requirements | Compared named issuer documents and their dates | That your plan uses any specific document |
| BMI and 5% tables | Calculated the values using the formulas printed above | Medical eligibility or guaranteed insurance approval |
| Patient accounts | Checked the dated public complaint and company-published quote | Typical results or independently verified service performance |
| Decision tables and worksheet | Assembled the policy, process and cost facts into next-action guides | A live insurance connection or an approval prediction |
What we couldn’t verify: your plan’s exact policy, a representative national Wegovy approval rate, whether your plan currently offers the $200 cap, or Ro’s insurance handling of HD 7.2 mg as a separate product. Ask those questions before spending money on care you do not need.
A safety note: this page is about coverage, not whether Wegovy is right for you. Wegovy has a boxed warning about thyroid C-cell tumors seen in rodents; whether it causes these tumors in humans is unknown. It is not for people with a personal or family history of medullary thyroid cancer or MEN 2. Wegovy is also contraindicated after a serious allergic reaction to semaglutide or its ingredients. Talk with your prescriber and read the full prescribing information.
How we judge telehealth programs: we use the RX Index Score, which weighs five things in this order — clinical legitimacy, care quality, transparency, access and cost. Ro and Sesame are discussed here because the question is about FDA-approved Wegovy and insurance paperwork. We did not calculate new provider scores or test their PA success rates for this article.
Who made this: The RX Index Editorial Team — independent guidance for choosing your GLP-1 path. We built this page because people with Express Scripts cards get conflicting answers, and the applicable plan documents help settle them. We earn money from some links. That never changes what the rules say. Read our methodology, editorial standards and corrections policy.
Express Scripts Wegovy prior authorization FAQ
Answer: These are the questions people ask next, checked against the same documents as the rest of this page.
Does Express Scripts require prior authorization for Wegovy? The Cigna documents compared here require a coverage review. Your own plan must cover the prescribed use or provide an applicable exception or override; an Express Scripts card alone does not prove coverage. Cigna policy index.
What BMI does Express Scripts require for Wegovy? In the standard adult weight-loss policy: 30 or higher, or 27 or higher with one listed condition, measured before the first GLP-1. The compared overrides use 32 or 35, or 27 with two listed conditions. Other treatment uses have different criteria. Standard policy · BMI-32 · BMI-35
How long does an Express Scripts prior authorization take? Express Scripts says nearly all reviews finish within two days after it gets complete information from your doctor. Some electronic requests can be decided in minutes. That is not an approval guarantee. Separate legal deadlines depend on the plan and claim type. Express Scripts · Department of Labor
Can I submit the prior authorization myself? You can help start and track the request, but the clinical answers must come from your doctor; Express Scripts says a pharmacist can help in some cases. Do not fill out clinician attestations yourself. Express Scripts.
What is the Express Scripts prior authorization phone number? Evernorth lists 800-753-2851 for prescriber PA assistance. Members should use the number on their prescription benefit ID card. TRICARE and plans with special instructions use their own contacts. Evernorth.
What is esrx.com/PA? It is the coverage-review address Express Scripts gives prescribers. Your doctor’s office can also use the electronic channels listed in the submission section. It is not a patient tool that confirms approval. Express Scripts formulary instructions.
Does Express Scripts cover the Wegovy pill? Your plan decides. Cigna publishes a separate Wegovy tablet policy with matching standard adult weight-loss criteria, but that does not prove the pill is covered under your benefit. Ask for the exact product’s coverage and PA requirements. Cigna tablet policy.
Does Express Scripts use AI to decide prior authorizations? Evernorth says an AI tool may help its clinical reviewers find information, but the tool does not make decisions or recommendations. That is Evernorth’s description of its process. Source.
I started Wegovy paying cash. Can insurance take over? It can if your benefit covers the prescribed use and the request meets its criteria. The compared Cigna policies use the baseline from before the first GLP-1. If you have completed at least 8 months of Wegovy treatment, ask the office whether the adult continuation criteria apply; paying cash does not itself qualify or disqualify the request. Cigna IP0814.
Can I take Wegovy and Ozempic together? Wegovy’s label says not to use it with another semaglutide product or another GLP-1 medicine. Have your clinician manage any switch and update the medication list. Prescribing information.
Why did my Wegovy coverage stop after 8 months? Eight months is the initial approval period in the compared Cigna weight-loss policies. A renewal needs the correct continuation evidence, including at least 5% weight loss for adults, plus the other requirements. Check the actual end date and reason on your notice. Cigna IP0814.
Does the Wegovy savings card work with Express Scripts? Eligible commercially insured patients with Wegovy coverage can use the offer, but Express Scripts Pharmacy cannot process manufacturer coupons at checkout. Check an eligible retail pharmacy or Novo’s mail-order reimbursement process. The commercial copay offer excludes government-plan members. Express Scripts · Novo terms
What if my plan excludes weight-loss drugs? Ask whether your benefit includes a weight-loss override or exception process. If not, you can discuss a clinically appropriate cash-pay prescription. The current Wegovy tablet offer starts at $149 for the 1.5 mg strength; the 25 mg maintenance strength is $299, and care fees can be extra. Cigna override policy · Novo prices
Still not sure which GLP-1 program is right for you? Take our free 2-minute matching quiz →
